These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32092486)

  • 21. Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma.
    Li X; Gao F; Meng X; Zhang X; Sun C; Liu H; Yu J; Liu X; Han X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Golchehre Z; Chavoshzadeh Z; Ren X; Wang X; Zhang H
    Br J Haematol; 2024 May; 204(5):1771-1779. PubMed ID: 38447995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma.
    Baecklund F; Foo JN; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
    Am J Epidemiol; 2017 Apr; 185(8):681-687. PubMed ID: 28369180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.
    Skibola CF; Berndt SI; Vijai J; Conde L; Wang Z; Yeager M; de Bakker PI; Birmann BM; Vajdic CM; Foo JN; Bracci PM; Vermeulen RC; Slager SL; de Sanjose S; Wang SS; Linet MS; Salles G; Lan Q; Severi G; Hjalgrim H; Lightfoot T; Melbye M; Gu J; Ghesquières H; Link BK; Morton LM; Holly EA; Smith A; Tinker LF; Teras LR; Kricker A; Becker N; Purdue MP; Spinelli JJ; Zhang Y; Giles GG; Vineis P; Monnereau A; Bertrand KA; Albanes D; Zeleniuch-Jacquotte A; Gabbas A; Chung CC; Burdett L; Hutchinson A; Lawrence C; Montalvan R; Liang L; Huang J; Ma B; Liu J; Adami HO; Glimelius B; Ye Y; Nowakowski GS; Dogan A; Thompson CA; Habermann TM; Novak AJ; Liebow M; Witzig TE; Weiner GJ; Schenk M; Hartge P; De Roos AJ; Cozen W; Zhi D; Akers NK; Riby J; Smith MT; Lacher M; Villano DJ; Maria A; Roman E; Kane E; Jackson RD; North KE; Diver WR; Turner J; Armstrong BK; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; McKay J; Brooks-Wilson AR; Zheng T; Holford TR; Chamosa S; Kaaks R; Kelly RS; Ohlsson B; Travis RC; Weiderpass E; Clavel J; Giovannucci E; Kraft P; Virtamo J; Mazza P; Cocco P; Ennas MG; Chiu BC; Fraumeni JF; Nieters A; Offit K; Wu X; Cerhan JR; Smedby KE; Chanock SJ; Rothman N
    Am J Hum Genet; 2014 Oct; 95(4):462-71. PubMed ID: 25279986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.
    Çağlayan Ç; Terawaki H; Ayer T; Goldstein JS; Rai A; Chen Q; Flowers C
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):300-309.e5. PubMed ID: 30686772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population.
    Salagovič J; Klimčáková L; Ilenčíková D; Kafková A
    Med Oncol; 2012 Jun; 29(2):1173-8. PubMed ID: 21476145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
    Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
    Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.
    Kelly JL; Salles G; Goldman B; Fisher RI; Brice P; Press O; Casasnovas O; Maloney DG; Soubeyran P; Rimsza L; Haioun C; Xerri L; LeBlanc M; Tilly H; Friedberg JW
    J Clin Oncol; 2015 May; 33(13):1482-90. PubMed ID: 25823738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
    El-Galaly TC; Bilgrau AE; de Nully Brown P; Mylam KJ; Ahmad SA; Pedersen LM; Gang AO; Bentzen HH; Juul MB; Bergmann OJ; Pedersen RS; Nielsen BJ; Johnsen HE; Dybkaer K; Bøgsted M; Hutchings M
    Br J Haematol; 2015 May; 169(3):435-44. PubMed ID: 25709094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.
    Kane EV; Bernstein L; Bracci PM; Cerhan JR; Costas L; Dal Maso L; Holly EA; La Vecchia C; Matsuo K; Sanjose S; Spinelli JJ; Wang SS; Zhang Y; Zheng T; Roman E; Kricker A;
    Ann Oncol; 2013 Feb; 24(2):433-441. PubMed ID: 22967995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
    Ritter AJ; Goldstein JS; Ayers AA; Flowers CR
    Leuk Lymphoma; 2019 Jul; 60(7):1656-1667. PubMed ID: 30632824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.
    Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward KC; Howard DH; Lee D; Flowers CR
    Leuk Lymphoma; 2017 Jul; 58(7):1570-1580. PubMed ID: 27830968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
    Nastoupil LJ; Sinha R; Byrtek M; Zhou X; Taylor MD; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
    Cancer; 2014 Jun; 120(12):1830-7. PubMed ID: 24668580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
    Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
    Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
    Batlevi CL; Sha F; Alperovich A; Ni A; Smith K; Ying Z; Soumerai JD; Caron PC; Falchi L; Hamilton A; Hamlin PA; Horwitz SM; Joffe E; Kumar A; Matasar MJ; Moskowitz AJ; Moskowitz CH; Noy A; Owens C; Palomba LM; Straus D; von Keudell G; Zelenetz AD; Seshan VE; Younes A
    Blood Cancer J; 2020 Jul; 10(7):74. PubMed ID: 32678074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
    Nabhan C; Byrtek M; Rai A; Dawson K; Zhou X; Link BK; Friedberg JW; Zelenetz AD; Maurer MJ; Cerhan JR; Flowers CR
    Br J Haematol; 2015 Jul; 170(1):85-95. PubMed ID: 25851937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study.
    Lee SF; Luque-Fernandez MA
    BMJ Open; 2017 Nov; 7(11):e017904. PubMed ID: 29101140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada.
    Le M; Ghazawi FM; Alakel A; Netchiporouk E; Rahme E; Zubarev A; Powell M; Moreau L; Roshdy O; Glassman SJ; Sasseville D; Popradi G; Litvinov IV
    Curr Oncol; 2019 Aug; 26(4):e473-e481. PubMed ID: 31548815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemiology Resource.
    Wudhikarn K; Smith BJ; Button AM; Habermann TM; Thompson CA; Rosenstein LJ; Syrbu SI; Weiner GJ; Cerhan JR; Link BK
    Leuk Lymphoma; 2015; 56(8):2365-72. PubMed ID: 25530345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.